Leadership
Causeway has assembled a formidable management team that have strong track records in drug development in companies ranging in size from start-up bio-techs through to large pharma. Significantly our team has specific experience in the development of miRNA therapeutics and world-leading clinical expertise in the investigation of musculoskeletal-soft-tissue disorders.
Dr. Derek S Gilchrist
Co-Founder and Chief Executive Officer |
Prof. Neal L Millar Co-Founder and Chief Medical Officer |
Declan Doogan Chairman
|
David Armour, Chief Financial Officer .
|
Iona Donnelly, Clinical Trial Director
|
